Citation Impact
Citing Papers
Final Version of 2009 AJCC Melanoma Staging and Classification
2009 Standout
T cell recognition of HLA‐A2 restricted tumor antigens is impaired by the oncogene HER2
2010
Treatment of kidney cancer
2009 StandoutNobel
Hypoxia-inducible factors 1?? and 2?? are related to vascular endothelial growth factor expression and a poorer prognosis in nodular malignant melanomas of the skin
2003
Decision aid on radioactive iodine treatment for early stage papillary thyroid cancer - a randomized controlled trial
2010
Diagnosis and Management of Pituitary Carcinomas
2005
Acromegaly
2006 Standout
Classification and Grading of Gastritis
1996 Standout
The Prognostic Importance of Tumor Mitotic Rate Confirmed in 1317 Patients With Primary Cutaneous Melanoma and Long Follow-Up
2004
Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines
1992
Cytokeratins in certain endothelial and smooth muscle cells of two taxonomically distant vertebrate species, Xenopus laevis and man
1987
The Systemic Amyloidoses
1997 Standout
Regulation of cancer cell metabolism by hypoxia-inducible factor 1
2008 StandoutNobel
Corticotroph Pituitary Carcinoma: Case Report and Literature Review
2001
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Signal integration by JNK and p38 MAPK pathways in cancer development
2009 Standout
Collagenous gastritis
1989
Biomarkers in melanoma: predisposition, screening and diagnosis
2003
Cushing's syndrome
2015 Standout
Dissemination and growth of cancer cells in metastatic sites
2002 Standout
The neuropeptide/mast cell secretagogue substance P is expressed in cutaneous melanocytic lesions
1998
Organ-Specific Molecular Classification of Primary Lung, Colon, and Ovarian Adenocarcinomas Using Gene Expression Profiles
2001
Metastatic Inefficiency
1990
Vincristine revisited
1999
Immunohistochemical Detection of Viral Antigens in Smooth Muscle, Stromal, and Epithelial Cells from Acute Human Cytomegalovirus Gastritis
1993
Senescence-associated secretory phenotype in a mouse model of bleomycin-induced lung injury
2013
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
2011 Standout
Daphnetin induced differentiation of human renal carcinoma cells and its mediation by p38 mitogen-activated protein kinase
2004
Naturally occurring antibodies devoid of light chains
1993 StandoutNature
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Lymphocytic (“microscopic”) colitis: A comparative histopathologic study with particular reference to collagenous colitis
1989 Standout
Vimentin—a new prognostic parameter in breast carcinoma?
1989
Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia
2000 Standout
Microtubules as a target for anticancer drugs
2004 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Biomarkers for epithelial-mesenchymal transitions
2009 Standout
Gene-expression profiles predict survival of patients with lung adenocarcinoma
2002 Standout
Differentiation and Risk Assessment of Gastrointestinal Stromal Tumors
1995
Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
2009 StandoutNobel
Infection in Organ-Transplant Recipients
1998 Standout
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Cancer Statistics, 2002
2002 Standout
LYSOSOMAL STORAGE DISEASES
1991
Cellular senescence: from physiology to pathology
2014 Standout
Cell migration and chimerism after whole-organ transplantation: The basis of graft acceptance
1993 Standout
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines
2008 Standout
Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance
1986
Low frequency of somatic mutation in beta-chain variable region genes of human T-cell receptors.
1985 StandoutNobel
Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells
1990 Standout
Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis
2002 Standout
Two E‐rosette‐forming lymphoid cell lines
1978
CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS
1974
Malignant lymphoma of mucosa-associated lymphoid tissue. A distinctive type of B-cell lymphoma
1983 Standout
Heavy Chain Diseases: Current Findings and Concepts
1979
c-ets1 proto-oncogene is a transcription factor expressed in endothelial cells during tumor vascularization and other forms of angiogenesis in humans.
1992
Chronic lymphocytic leukemia
1978
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
2011 Standout
Gluten, major histocompatibility complex, and the small intestine
1992 Standout
Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera.
1981 Standout
Lectins: Carbohydrate-Specific Proteins That Mediate Cellular Recognition
1998 Standout
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Decision aids for people facing health treatment or screening decisions
2017 Standout
Attempts to demonstrate virus‐specific sequences in human tumors. IV. EB viral DNA in European burkitt lymphoma and immunoblastic lymphadenopathy with excessive plasmacytosis
1976 StandoutNobel
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
1986
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
1996 Standout
Deletions in immunoglobulin mu chains.
1982 StandoutNobel
Oxygen Sensing, Hypoxia-Inducible Factors, and Disease Pathophysiology
2013 StandoutNobel
Indications for Marrow Transplantation
1984 StandoutNobel
Immunohistological Analysis of Human Lymphoma: Correlation of Histological and Immunological Categories
1984
Ig V Gene Mutation Status and CD38 Expression As Novel Prognostic Indicators in Chronic Lymphocytic Leukemia
1999 Standout
TRACP Influences Th1 Pathways by Affecting Dendritic Cell Function
2006 StandoutNobel
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia. I. Clinical and laboratory features of 300 patients and characterization of an intermediate group.
1986
Regulation of matrix metalloproteinase expression in tumor invasion
1999 Standout
The Disorder in Childhood
1974
Investigation of a new parameter in chronic lymphocytic leukemia: The percentage of large peripheral lymphocytes determined by the Hemalog D
1977
Amyloidosis and plasma cell dyscrasias: Gastrointestinal involvement
1986
Unmutated Ig VH Genes Are Associated With a More Aggressive Form of Chronic Lymphocytic Leukemia
1999 Standout
Clinical Approach to Genetic Cardiomyopathy in Children
1996
Progression and survival studies in early chronic lymphocytic leukemia
1991
A clinical staging system for chronic lymphocytic leukemia.Prognostic significance
1977
The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells
1985 Standout
Identification of a Pure Splenic Form of Chronic Lymphocytic Leukaemia
1979
Pituitary Carcinoma: A Clinicopathological Review
2005
Pathological study of alpha-chain disease, with special emphasis on evolution
1977
Progression of Neurovisceral Storage Disease With Supranuclear Ophthalmoplegia Following Orthotopic Liver Transplantation
1986
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
1986
BCL2 translocations in leukemias of mature B cells
1994
Fine Structure of the Small Intestinal Mucosa in Infantile Marasmic Malnutrition
1976
Prolymphocytic Leukemia with T Cell Properties and Tartrate Resistant Acid Phosphatase
1977
Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): Histopathologic findings in 15 patients
1987
Chronic Lymphocytic Leukemia
1984
Immunogenic Cell Death in Cancer Therapy
2012 Standout
A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis
1981 Standout
The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia
1987
Prognostic Factors in Chronic Lymphocytic Leukaemia and Their Implications for Therapy
1977
Works of K. Henry being referenced
Alpha-chain Disease with Clinical, Immunological, and Histological Recovery
1974
Overexpression of HER-2 in thick melanoma
2002
Pituitary Carcinoma: An Ultrastructural Study of Eleven Cases
2001
Prognostic factors of cutaneous melanoma and a new staging system proposed by the American Joint Committee on Cancer (AJCC)
2002
Subepithelial collagen in intestinal malabsorption.
1975
Reversal of clinical features of hurler's disease and biochemical improvement after treatment by bone marrow transplantation
1982
An immunological study of adult coeliac disease.
1972
Reduction of vincristine toxicity by Cronassial
1987
Staining for factor VIII related antigen and Ulex europaeus agglutinin I (UEA‐I) in 230 tumours. An assessment of their specificity for angiosarcoma and Kaposi's sarcoma
1986
Cytomegalovirus gastritis with perforation and gastrocolic fistula formation
1991
Radiological and histological findings in six patients with alpha-chain disease
1976
Antineuron specific enolase staining reactions in sarcomas and carcinomas: its lack of neuroendocrine specificity.
1986
Vimentin: an evaluation of its role as a tumour marker
1987
Five cases of alpha chain disease
1972
Electron microscopy in the non-Hodgkin's lymphomata.
1975
Prolymphocytic Leukaemia
1974
An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas
1986